Eli Lilly goes big on AI-generated drug discovery - Morning Brew
Eli Lilly made a $2.75 billion deal with Hong Kong-based Insilico Medicine, a startup that uses AI to accelerate drug discovery. Under the terms:.
Read the original at morningbrew.com ↗
- Tracked via
- “that uses AI to”